Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Genet ; 92(4): 423-429, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28139846

RESUMO

SATB2-associated syndrome (SAS) is a multisystemic disorder caused by alterations of the SATB2 gene. We describe the phenotype and genotype of 12 individuals with 10 unique (de novo in 11 of 11 tested) pathogenic variants (1 splice site, 5 frameshift, 3 nonsense, and 2 missense) in SATB2 and review all cases reported in the published literature caused by point alterations thus far. In the cohort here described, developmental delay (DD) with severe speech compromise, facial dysmorphism, and dental anomalies were present in all cases. We also present the third case of tibial bowing in an individual who, just as in the previous 2 individuals in the literature, also had a truncating pathogenic variant of SATB2. We explore early genotype-phenotype correlations and reaffirm the main clinical features of this recognizable syndrome: universal DD with severe speech impediment, mild facial dysmorphism, and high frequency of craniofacial anomalies, behavioral issues, and brain neuroradiographic changes. As the recently proposed surveillance guidelines for individuals with SAS are adopted by providers, further delineation of the frequency and impact of other phenotypic traits will become available. Similarly, as new cases of SAS are identified, further exploration of genotype-phenotype correlations will be possible.


Assuntos
Anormalidades Craniofaciais/genética , Deficiências do Desenvolvimento/genética , Deficiência Intelectual/genética , Proteínas de Ligação à Região de Interação com a Matriz/genética , Fatores de Transcrição/genética , Adolescente , Criança , Pré-Escolar , Anormalidades Craniofaciais/fisiopatologia , Deficiências do Desenvolvimento/fisiopatologia , Exoma/genética , Feminino , Mutação da Fase de Leitura , Estudos de Associação Genética , Predisposição Genética para Doença , Genótipo , Humanos , Lactente , Deficiência Intelectual/fisiopatologia , Masculino , Fenótipo
2.
Mol Psychiatry ; 19(3): 368-79, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23587880

RESUMO

Microdeletions of chromosomal region 2q23.1 that disrupt MBD5 (methyl-CpG-binding domain protein 5) contribute to a spectrum of neurodevelopmental phenotypes; however, the impact of this locus on human psychopathology has not been fully explored. To characterize the structural variation landscape of MBD5 disruptions and the associated human psychopathology, 22 individuals with genomic disruption of MBD5 (translocation, point mutation and deletion) were identified through whole-genome sequencing or cytogenomic microarray at 11 molecular diagnostic centers. The genomic impact ranged from a single base pair to 5.4 Mb. Parents were available for 11 cases, all of which confirmed that the rearrangement arose de novo. Phenotypes were largely indistinguishable between patients with full-segment 2q23.1 deletions and those with intragenic MBD5 rearrangements, including alterations confined entirely to the 5'-untranslated region, confirming the critical impact of non-coding sequence at this locus. We identified heterogeneous, multisystem pathogenic effects of MBD5 disruption and characterized the associated spectrum of psychopathology, including the novel finding of anxiety and bipolar disorder in multiple patients. Importantly, one of the unique features of the oldest known patient was behavioral regression. Analyses also revealed phenotypes that distinguish MBD5 disruptions from seven well-established syndromes with significant diagnostic overlap. This study demonstrates that haploinsufficiency of MBD5 causes diverse phenotypes, yields insight into the spectrum of resulting neurodevelopmental and behavioral psychopathology and provides clinical context for interpretation of MBD5 structural variations. Empirical evidence also indicates that disruption of non-coding MBD5 regulatory regions is sufficient for clinical manifestation, highlighting the limitations of exon-focused assessments. These results suggest an ongoing perturbation of neurological function throughout the lifespan, including risks for neurobehavioral regression.


Assuntos
Ansiedade/genética , Transtorno Bipolar/genética , Proteínas de Ligação a DNA/genética , Deficiências do Desenvolvimento/genética , Predisposição Genética para Doença/genética , Estudo de Associação Genômica Ampla , Humanos , Mutação
3.
Clin Genet ; 79(5): 468-74, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-20735442

RESUMO

BRAF, the protein product of BRAF, is a serine/threonine protein kinase and one of the direct downstream effectors of Ras. Somatic mutations in BRAF occur in numerous human cancers, whereas germline BRAF mutations cause cardio-facio-cutaneous (CFC) syndrome. One recurrent somatic mutation, p.V600E, is frequently found in several tumor types, such as melanoma, papillary thyroid carcinoma, colon cancer, and ovarian cancer. However, a germline mutation affecting codon 600 has never been described. Here, we present a patient with CFC syndrome and a de novo germline mutation involving codon 600 of BRAF, thus providing the first evidence that a pathogenic germline mutation involving this critical codon is not only compatible with development but can also cause the CFC phenotype. In vitro functional analysis shows that this mutation, which replaces a valine with a glycine at codon 600 (p.V600G), leads to increased ERK and ELK phosphorylation compared to wild-type BRAF but is less strongly activating than the cancer-associated p.V600E mutation.


Assuntos
Códon/genética , Mutação em Linhagem Germinativa , Proteínas Proto-Oncogênicas B-raf/genética , Adulto , Sequência de Bases , Pré-Escolar , Displasia Ectodérmica/genética , MAP Quinases Reguladas por Sinal Extracelular/genética , Face , Fácies , Insuficiência de Crescimento/genética , Feminino , Genótipo , Cardiopatias Congênitas/genética , Humanos , Masculino , Dados de Sequência Molecular , Fenótipo
4.
Clin Genet ; 69(4): 349-54, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16630169

RESUMO

Lacrimo-auriculo-dento-digital syndrome [LADD (MIM 149730)] is an autosomal-dominant multiple congenital anomaly disorder characterized by aplasia, atresia or hypoplasia of the lacrimal and salivary systems, cup-shaped ears, hearing loss, and dental and digital anomalies. Loss of function mutations in FGF10 were recently described in aplasia of the lacrimal and salivary glands [ALSG (MIM 180920; MIM 103420)] (Entesarian et al., Nat Genet 2005: 37: 125-127, Milunsky et al., American College of Medical Genetics Annual Meeting, Dallas, TX, 2005: A100). Due to the significant phenotypic overlap between LADD syndrome and ALSG and the variable expressivity of both the disorders, we hypothesized that FGF10 mutations could also result in LADD syndrome. A de novo missense mutation was found in exon 3 of FGF10 in a 3-year-old female (Family 1) with LADD syndrome. This missense mutation, resulting in a non-conservative amino acid change, was confirmed by restriction enzyme digestion and was not found in 500 control chromosomes. A nonsense mutation was also found in exon 2 of FGF10 (Family 2) in a 19-year-old mother with ALSG and her 2-year-old daughter with LADD syndrome. Previous studies of FGF10 mutant mice have demonstrated abnormalities consistent with ALSG and LADD syndrome. We conclude that ALSG and LADD syndrome may represent variable presentations of the same clinical spectrum caused by FGF10 mutations.


Assuntos
Anormalidades Múltiplas/genética , Orelha Externa/anormalidades , Fator 10 de Crescimento de Fibroblastos/genética , Aparelho Lacrimal/anormalidades , Mutação , Glândulas Salivares/anormalidades , Anormalidades Dentárias/genética , Adulto , Sequência de Bases , Pré-Escolar , Feminino , Fator 10 de Crescimento de Fibroblastos/metabolismo , Humanos , Dados de Sequência Molecular , Polimorfismo de Nucleotídeo Único , Síndrome
6.
J Pediatr ; 137(1): 123-7, 2000 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10891834

RESUMO

We conducted a retrospective study that compared serial alpha-fetoprotein (AFP) concentrations obtained from 22 children with Beckwith-Wiedemann syndrome (BWS) with levels established for healthy children. The AFP concentration is greater in patients with BWS and declines during the postnatal period at a significantly slower rate than what is reported in healthy children. AFP levels obtained in the course of routine tumor screening in children with BWS should be interpreted with a normal curve established specifically for BWS rather than with previously published data for healthy infants and children.


Assuntos
Síndrome de Beckwith-Wiedemann/sangue , alfa-Fetoproteínas/análise , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Estudos Retrospectivos
9.
Psychosomatics ; 35(1): 35-40, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-8134527

RESUMO

A patient with bipolar disorder and previously undiagnosed Klinefelter's syndrome presented with acute mania refractory to pharmacotherapy and was successfully treated with electroconvulsive therapy. This case constitutes the 31st case report documenting the coexistence of bipolar disorder with chromosomal anomalies and the 14th such patient with Klinefelter's syndrome. The relevance of this case to understanding the genetics of bipolar disorder is explored through a review of previously published reports of bipolar patients with chromosomal abnormalities. The relatively high incidence of Klinefelter's syndrome among this group of patients is discussed in the context of evidence for linkage of bipolar illness to the X chromosome.


Assuntos
Transtorno Bipolar/etiologia , Aberrações Cromossômicas/diagnóstico , Síndrome de Klinefelter/complicações , Adulto , Transtorno Bipolar/diagnóstico , Aberrações Cromossômicas/genética , Transtornos Cromossômicos , Cromossomos Humanos Par 9 , Humanos , Cariotipagem , Síndrome de Klinefelter/genética , Masculino , Escalas de Graduação Psiquiátrica , Cromossomo X
10.
Biochem Pharmacol ; 41(11): 1701-5, 1991 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-1645968

RESUMO

Spin trapping of free radicals during the hepatic metabolism of tamoxifen was investigated; the spin trap employed in this study was 5,5-dimethyl-1-pyrroline-1-oxide (DMPO). The spin adduct 2-hydroxy-5,5-dimethyl-1-pyrrolidinyloxyl (DMPO-OH) was detected in an in vitro incubation mixture of phenobarbital-treated rat hepatocytes containing tamoxifen, dimethyl sulfoxide, and DMPO. However, since the spin adduct 2,5,5-trimethyl-1-pyrrolidinyloxyl (DMPO-CH3) was not observed, the DMPO-OH resulted from the cellular bioreduction of 2-hydroperoxy-5,5-dimethyl-1-pyrrolidinyloxyl (DMPO-OOH) by glutathione peroxidase. Addition of superoxide dismutase (SOD) to the in vitro system indicated that superoxide production was intracellular. When noninduced hepatocytes were utilized, free radical production was not evident. Thus, the cytochrome P450 monooxygenase system was responsible, in part, for the intermediacy of superoxide anion during hepatic metabolism.


Assuntos
Fígado/metabolismo , Superóxidos/metabolismo , Tamoxifeno/metabolismo , Animais , Óxidos N-Cíclicos , Espectroscopia de Ressonância de Spin Eletrônica , Radicais Livres , Glutationa Peroxidase/metabolismo , Hidróxidos/metabolismo , Radical Hidroxila , Masculino , Ratos , Ratos Endogâmicos F344
11.
Free Radic Biol Med ; 9(5): 415-21, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-1963415

RESUMO

Experiments were conducted to determine which free radicals are generated during the metabolism of adriamycin (ADM) by canine tracheal epithelial (CTE) cells, guinea pig enterocytes, and rat hepatocytes. The technique employed in this study was spin trapping; the spin trap utilized was 5,5-dimethyl-1-pyrroline-1-oxide (DMPO). The spin adduct 2-hydroxy-5,5-dimethyl-1-pyrrolidinyloxyl (DMPO-OH) was observed during the metabolism of ADM by CTE cells. However, the addition of dimethyl sulfoxide to the in vitro system suggested that superoxide is initially spin trapped by the nitrone, and that the adduct 2-hydroperoxy-5,5-dimethyl-1-pyrrolidinyloxyl (DMPO-OOH) is rapidly bioreduced to afford DMPO-OH. The addition of superoxide dismutase to the system indicated that superoxide generation was primarily intracellular. The adriamycin semiquinone free radical (ADM-SQ) was produced during the metabolism by enterocytes and hepatocytes. The rate of the production of ADM-SQ was enhanced under anaerobic conditions, suggesting that molecular oxygen was responsible for the degradation of this carbon-centered free radical. However, spin trapping of oxygen radicals was not observed; this observation suggests that these reactive intermediates are not produced at concentrations sufficient for detection by spin-trapping experiments.


Assuntos
Doxorrubicina/metabolismo , Animais , Cães , Doxorrubicina/química , Espectroscopia de Ressonância de Spin Eletrônica , Radicais Livres , Cobaias , Hidróxidos/metabolismo , Radical Hidroxila , Técnicas In Vitro , Mucosa Intestinal/metabolismo , Fígado/metabolismo , Masculino , Ratos , Ratos Endogâmicos F344 , Superóxidos/metabolismo , Traqueia/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...